Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2023 Filed Aug 3, 2023 00:25 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantPerformance Share Units · Derivative | 7,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000086 · wk-form4_1691022299.xml · derivative · entry 2 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,122 Underlying: Performance Share Unit · 7,122 shares Expires not disclosed F3 · derivative.exercise_price: This performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 7,122 shares will be issued. If maximum performance metrics are achieved, 14,244 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 00:25 UTC |
Kirk Jennifer MChief Accounting Officer
|
GrantOrdinary Shares | 2,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000086 · wk-form4_1691022299.xml · nonDerivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,376 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 114 units acquired through dividend reinvestment and 298 units acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:53 UTC |
Salmon SeanEVP & President Cardiovascular
|
GrantStock Option (Right to Buy) · Derivative | 68,196 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000076 · wk-form4_1691020401.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,196 Underlying: Ordinary Shares · 68,196 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:53 UTC |
Salmon SeanEVP & President Cardiovascular
|
GrantPerformance Share Units · Derivative | 21,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000076 · wk-form4_1691020401.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,214 Underlying: Performance Share Unit · 21,214 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,214 shares will be issued. If maximum performance metrics are achieved, 48,428 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:53 UTC |
Salmon SeanEVP & President Cardiovascular
|
GrantOrdinary Shares | 9,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000076 · wk-form4_1691020401.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,290 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 516 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:49 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
GrantStock Option (Right to Buy) · Derivative | 48,139 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001613103-23-000074 · wk-form4_1691020176.xml · derivative · entry 3 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,139 Underlying: Ordinary Shares · 48,139 shares Expires 2033-07-31 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:49 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
GrantPerformance Share Units · Derivative | 17,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000074 · wk-form4_1691020176.xml · derivative · entry 2 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,093 Underlying: Performance Share Unit · 17,093 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,093 shares will be issued. If maximum performance metrics are achieved, 34,186 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F5 · derivative.exercise_date: Vests on July 31, 2026. F5 · derivative.expiration_date: Vests on July 31, 2026. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 23:49 UTC |
Marinaro MichaelEVP & President, Surgical OU
|
GrantOrdinary Shares | 6,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-23-000074 · wk-form4_1691020176.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP & President, Surgical OU 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,890 F1 · shares: Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. F2 · balance_after: Includes 155 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 14, 2023 Filed Jul 18, 2023 20:16 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
SaleOrdinary Shares | 2,000 | $87.97 | $175,940.00 |
DisclosureSEC source: 0001613103-23-000054 · wk-form4_1689711392.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,948 F1 · kind: This transaction was made pursuant to the reporting person's existing Rule 10b5-1 plan. F2 · balance_after: Includes 478 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 15:48 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,706 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001613103-23-000050 · wk-form4_1689191286.xml · derivative · entry 6 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,706 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are fully vested. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 15:48 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,808 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001613103-23-000050 · wk-form4_1689191286.xml · derivative · entry 5 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,706 Underlying: Ordinary Shares · 1,808 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options are fully vested. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 15:48 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
SaleOrdinary Shares | 3,706 | $86.58 | $320,865.48 |
DisclosureSEC source: 0001613103-23-000050 · wk-form4_1689191286.xml · nonDerivative · entry 4 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,802 Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 15:48 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionOrdinary Shares | 3,706 | $55.32 | $205,015.92 |
DisclosureSEC source: 0001613103-23-000050 · wk-form4_1689191286.xml · nonDerivative · entry 3 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 15:48 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
SaleOrdinary Shares | 1,808 | $86.59 | $156,554.72 |
DisclosureSEC source: 0001613103-23-000050 · wk-form4_1689191286.xml · nonDerivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,802 Read SEC document |
| July 10, 2023 Filed Jul 12, 2023 15:48 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionOrdinary Shares | 1,808 | $55.32 | $100,018.56 |
DisclosureSEC source: 0001613103-23-000050 · wk-form4_1689191286.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 319 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 02, 2023 Filed May 3, 2023 16:35 UTC |
OLEARY DENISE MDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000029 · wf-form4_168314610458049.xml · nonDerivative · entry 2 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,838 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:34 UTC |
Lofton Kevin EDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000027 · wf-form4_168314604786031.xml · nonDerivative · entry 2 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,191 F3 · shares: Represents shares withheld for payment of withholding taxes upon the vesting of previously reported restricted stock units. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:34 UTC |
Powell Kendall JDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000028 · wf-form4_168314606438355.xml · nonDerivative · entry 2 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,992 F3 · shares: Represents shares withheld for payment of withholding taxes upon the vesting of previously reported restricted stock units. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:33 UTC |
DONNELLY SCOTT CDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000025 · wf-form4_168314600021928.xml · nonDerivative · entry 2 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,576 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:33 UTC |
ARNOLD CRAIGDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000024 · wf-form4_168314598022497.xml · nonDerivative · entry 2 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,236 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:32 UTC |
HOGAN RANDALL JDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000023 · wf-form4_168314595745230.xml · nonDerivative · entry 2 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,964 F3 · shares: Represents shares withheld for payment of withholding taxes upon the vesting of previously reported restricted stock units. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:32 UTC |
ANDERSON RICHARD HDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000021 · wf-form4_168314589697432.xml · nonDerivative · entry 2 ANDERSON RICHARD H · CIK 0001200334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,023 F3 · shares: Represents shares withheld for payment of withholding taxes upon vesting of previously reported restricted stock units. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:32 UTC |
Goldsmith Andrea JoDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000022 · wf-form4_168314592604750.xml · nonDerivative · entry 2 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,267 F3 · shares: Represents shares withheld for payment of withholding taxes upon the vesting of previously reported restricted stock units. Read SEC document |
| May 02, 2023 Filed May 3, 2023 20:31 UTC |
NABEL ELIZABETH GDirector
|
Tax withholdingOrdinary Shares | 169 | $90.23 | $15,248.87 |
DisclosureSEC source: 0001613103-23-000020 · wf-form4_168314585980107.xml · nonDerivative · entry 2 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,635 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| May 01, 2023 Filed May 3, 2023 16:35 UTC |
OLEARY DENISE MDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000029 · wf-form4_168314610458049.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,007 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 1,160 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:34 UTC |
Lofton Kevin EDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000027 · wf-form4_168314604786031.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,360 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 56 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:34 UTC |
Fonseca LidiaDirector
|
GrantOrdinary Shares | 1,624 | $90.68 | $147,264.32 |
DisclosureSEC source: 0001613103-23-000026 · wf-form4_168314602841816.xml · nonDerivative · entry 1 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,624 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:34 UTC |
Powell Kendall JDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000028 · wf-form4_168314606438355.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,161 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 814 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:33 UTC |
DONNELLY SCOTT CDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000025 · wf-form4_168314600021928.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,745 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 133 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:33 UTC |
ARNOLD CRAIGDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000024 · wf-form4_168314598022497.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,405 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 56 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:32 UTC |
HOGAN RANDALL JDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000023 · wf-form4_168314595745230.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,133 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 56 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:32 UTC |
ANDERSON RICHARD HDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000021 · wf-form4_168314589697432.xml · nonDerivative · entry 1 ANDERSON RICHARD H · CIK 0001200334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,192 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 1,080 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:32 UTC |
Goldsmith Andrea JoDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000022 · wf-form4_168314592604750.xml · nonDerivative · entry 1 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,436 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 56 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| May 01, 2023 Filed May 3, 2023 20:31 UTC |
NABEL ELIZABETH GDirector
|
GrantOrdinary Shares | 1,930 | $90.68 | $175,012.40 |
DisclosureSEC source: 0001613103-23-000020 · wf-form4_168314585980107.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,804 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 56 units acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 20:11 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Tax withholdingOrdinary Shares | 74 | $80.71 | $5,972.54 |
DisclosureSEC source: 0001127602-23-013287 · form4.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,882 F1 · shares: Represents Ordinary Shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. F2 · balance_after: This balance increased by 377 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 16:02 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Tax withholdingOrdinary Shares | 6,866 | $80.27 | $551,133.82 |
DisclosureSEC source: 0001127602-23-012715 · form4.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,579 F1 · shares: Represents Ordinary Shares withheld for payment of withholding taxes in connection with the vesting on April 5, 2023 of restricted stock units previously reported on Table I. F2 · balance_after: This balance increased by 662 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:47 UTC |
Kirk Jennifer MChief Accounting Officer
|
Tax withholdingOrdinary Shares | 672 | $85.77 | $57,637.44 |
DisclosureSEC source: 0001127602-23-003128 · form4.xml · nonDerivative · entry 1 Kirk Jennifer M · CIK 0001613343 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,115 F1 · shares: The reported transaction involved the withholding of 672 shares of stock issuable upon the vesting of certain restricted stock units. F2 · balance_after: This balance increased by 157 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,823 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · derivative · entry 5 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,823 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,808 | $0.00 Strike: $55.32 | $0.00 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · derivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,808 shares Expires 2023-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC |
Salmon SeanEVP & President Cardiovascular
|
SaleOrdinary Shares | 16,631 | $80.50 | $1,338,735.63 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · nonDerivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,088 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.48 to $80.545 inclusive. The reporting person undertakes to provide Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 14,823 | $55.32 | $820,008.36 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · nonDerivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 16, 2022 12:28 UTC |
Salmon SeanEVP & President Cardiovascular
|
Exercise / conversionOrdinary Shares | 1,808 | $55.32 | $100,018.56 |
DisclosureSEC source: 0001127602-22-027593 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 16:57 UTC |
Fong Ivan KEVP GENERAL COUNSEL & SECR
|
Tax withholdingOrdinary Shares | 5,206 | $78.59 | $409,139.54 |
DisclosureSEC source: 0001127602-22-027403 · form4.xml · nonDerivative · entry 1 Fong Ivan K · CIK 0001342238 · EVP GENERAL COUNSEL & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,830 F1 · balance_after: This balance increased by 314 shares due to exempt acquisitions through dividend reinvestment. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 16:48 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
Tax withholdingOrdinary Shares | 348 | $79.04 | $27,505.92 |
DisclosureSEC source: 0001127602-22-027200 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,186 F1 · balance_after: This balance increased by 183 shares due to exempt acquisitions through dividend reinvestment. F2 · balance_after: The reported transaction involved the withholding of 348 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:47 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
Tax withholdingOrdinary Shares | 337 | $79.04 | $26,636.48 |
DisclosureSEC source: 0001127602-22-027197 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,470 F1 · balance_after: This balance increased by 161 shares due to exempt acquisitions through dividend reinvestment. F2 · balance_after: The reported transaction involved the withholding of 337 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:45 UTC |
Salmon SeanEVP & President Cardiovascular
|
Tax withholdingOrdinary Shares | 300 | $79.04 | $23,712.00 |
DisclosureSEC source: 0001127602-22-027194 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & President Cardiovascular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,088 F1 · balance_after: This balance increased by 174 shares due to exempt acquisitions through dividend reinvestment. F2 · balance_after: The reported transaction involved the withholding of 300 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 18:08 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,404 | $0.00 Strike: $41.60 | $0.00 |
DisclosureSEC source: 0001127602-22-023986 · form4.xml · derivative · entry 3 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,404 shares Expires 2022-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 18:08 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
SaleOrdinary Shares | 2,404 | $81.54 | $196,014.95 |
DisclosureSEC source: 0001127602-22-023986 · form4.xml · nonDerivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,483 Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 18:08 UTC |
TEN HOEDT ROBEVP and Pres. Global Regions
|
Exercise / conversionOrdinary Shares | 2,404 | $41.60 | $100,006.40 |
DisclosureSEC source: 0001127602-22-023986 · form4.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP and Pres. Global Regions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:29 UTC |
WHITE ROBERT JOHNEVP & Pres. Medical Surgical
|
GrantStock Option (Right to Buy) · Derivative | 67,924 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020408 · form4.xml · derivative · entry 4 WHITE ROBERT JOHN · CIK 0001726709 · EVP & Pres. Medical Surgical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,924 Underlying: Ordinary Shares · 67,924 shares Expires 2032-08-01 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.